Pharma Stock to Buy: The domestic stock market had a flat start on Wednesday (August 28). In a rangebound market, some stocks can show good action on the technical chart.
A brokerage firm has made pharma sector stock Lupin Ltd (NSE: LUPIN) a technical pick. The brokerage has advised buying Lupin Ltd with a 2-3 day perspective.
Indian stock markets had a flat start on Wednesday. However, after this, Nifty reached a new record level around 11:40.
The index crossed 25,100 for the first time with a gain of 80 points. Sensex is also up by more than 200 points. In the opening, the Sensex opened with a gain of 70 points around the level of 81,781.
At the same time, Nifty opened above 25,030 with a gain of 12 points. There was a good rise in IT and auto stocks.
Lupin: Big Profit In 2-3 Days
The brokerage house has made Lupin Ltd a technical pick. A position has to be taken in this stock with a view to the next 2-3 days.
The target price is Rs 2280. On August 27, 2024, the stock closed at Rs 2171. This way, the price could rise 5 to 6 percent above its current price.
Lupin: Stock Jumped 20% In 1 Month
Lupin Ltd started trading with a rise on Wednesday in a sluggish market. The stock climbed 1 % in the first trading session. Over the past year, the stock has recorded a gain of approximately 100 %.
In 2024, the stock has earned 65 % return. At the same time, the stock has jumped 35 percent in 6 months, 36 percent in 3 months, and 20 percent in 1 month.
The stock’s 52-week high on BSE is 2,195.40 and the low is 1,088.30. The company’s market capitalization is greater than the sum of 99,958 crore rupees.
Lupin Ltd Stock Performance
| Market Cap | ₹ 1,00,287 Cr. |
| Current Price | ₹ 2,200 |
| 52-wk High | ₹ 2,228 |
| 52-wk Low | ₹ 1,087 |
| 5 days Return | 4.65% |
| 1 Month Return | 18.15% |
Company’s Fundamentals
| Stock P/E | 44.3 |
| Book Value | ₹ 314 |
| Dividend | 0.36 % |
| ROCE | 15.7 % |
| ROE | 14.1 % |
| Face Value | ₹ 2.00 |
| P/B Value | 7.02 |
| OPM | 20.2 % |
| EPS | ₹ 49.7 |
| Debt | ₹ 2,922 Cr. |
| Debt to Equity | 0.20 |
| Promoters | 46.99% |
| FII’s | 19.32% |
| DII’s | 26.77% |
| Govt. | 0.01% |
| Public | 6.92% |
Last 5 Years’ Sales (Figures in Rs. Crores)
| Year | Sales |
| 2020 | 15,375 |
| 2021 | 15,163 |
| 2022 | 16,405 |
| 2023 | 16,642 |
| 2024 | 20,797 |
Last 5 Years’ Net Profit (Figures in Rs. Crores)
| Year | Net Profit |
| 2020 | -270 |
| 2021 | 1,228 |
| 2022 | -1,528 |
| 2023 | 448 |
| 2024 | 2,288 |
Disclaimer: The website and its content are for informational purposes only and should not be considered investment advice.
